Inovio earnings call
WebAug 9, 2024 · Inovio Pharmaceuticals (NASDAQ: INO) Q2 2024 Earnings Call. Aug 09, 2024, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; … WebApr 13, 2024 · Inovio Pharmaceuticals - INO Stock Forecast, Price & News $0.73 0.00 (0.00%) (As of 04/11/2024 12:00 AM ET) Compare Today's Range $0.70 $0.74 50-Day Range $0.70 $1.91 52-Week Range $0.69 $3.45 Volume 6.73 million shs Average Volume 4.90 million shs Market Capitalization $189.63 million P/E Ratio N/A Dividend Yield N/A Price …
Inovio earnings call
Did you know?
WebMay 10, 2024 · Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Conference Call May 10, 2024 4:30 PM ET Company Participants Ben Matone - Senior Director of IR Joseph Kim - President and CEO... WebInovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and …
WebNov 8, 2024 · INOVIO reported total revenue of $9.2 million for the three months ended, September 30, 2024, compared to $292,000 for the same period in 2024. The increase in revenue resulted from the... WebMar 1, 2024 · Inovio Pharmaceuticals, Inc. - INOVIO Reports Fourth Quarter 2024 and Year-End Financial Results INVESTORS & MEDIA News Details View all news INOVIO Reports Fourth Quarter 2024 and Year-End Financial Results March 01, 2024 Download Investor … At INOVIO, we promise to treat your data with respect and will not share your … Disease Program Study Phase Summary; DiseaseBRCA1/2 Mutation Carriers (More … Ms. Gevgilili joins INOVIO from Allergan (acquired by AbbVie), where she spent …
WebAug 9, 2024 · INOVIO's research and development expenses for the 3 months ended June 30, 2024, were $56.5 million compared to $70.8 million for the same period in 2024. WebMar 13, 2024 · At INOVIO, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are …
WebMar 1, 2024 · Inovio, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.13 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by...
Web1 day ago · Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript. 2 Stocks to Sell or Remove From Your Watchlist in 2024. Inovio Pharmaceuticals (INO) Q3 2024 Earnings … cchc neurology new bernWebAug 10, 2024 · Inovio Pharmaceuticals, Inc. ( NASDAQ: INO) Q2 2024 Earnings Conference Call August 9, 2024 4:30 PM ET Company Participants Thomas Hong - IR Jacqueline Shea - CEO, President & Director... cchc morehead cityWebAug 9, 2024 · The increase in revenue resulted from the delivery of Inovio's proprietary smart devices related to our contract with the U.S. Department of Defense. Total operating expenses were $104.9 million... cchc monterey caWebApr 13, 2024 · Inovio Pharmaceuticals, Inc. (INO) latest earnings report: revenue, EPS, surprise, history, news and analysis. cchc new bern familyWebMar 1, 2024 · Thanks, Joseph, and good afternoon, everyone. We ended the fourth quarter with $401.3 million in cash, cash equivalents and short term investments compared to $411.6 million as of December 31 ... cchc mental healthWebMar 6, 2024 · Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Q4 2024 Earnings Call Transcript March 1, 2024 Operator: Good afternoon, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2024 Financial... buster wells texasWebApr 11, 2024 · Immunological data from recently completed Phase 1b trial will be presented on April 16 th. PLYMOUTH MEETING, Pa., April 12, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and … cchc new bern